Apprentice.io is an intelligent software company and is the creator of a conversational augmented reality (AR) and artificial intelligence (AI) platform.
Apprentice's disruptive technology helps pharma manufacturers get medicine to patients faster by providing one platform to turn molecules into medicine.
Apprentice.io was founded in 2014 by Angelo Stracquatanio. The company is headquartered in Jersey City, New Jersey.
Apprentice's intelligent cloud platform integrates augmented reality, voice recognition, and artificial intelligence into wearable, mobile, and desktop devices to offer a virtual collaboration application and a robust manufacturing and lab execution system that reduce human error and inefficiency in the drug production process.
Apprentice's cloud-based manufacturing platform helped legacy facilities transform at a radical pace - directly supporting creation of an estimated 370 million COVID-19 vaccine doses and counting.
Apprentice supports Fortune 100 clients in life sciences and other complex, compliance-driven industries worldwide. Currently 15 of the top 20 US Pharma companies use Apprentice to accelerate high-quality production of drugs for diseases of all types, from COVID to cancer.
Apprentice is backed by Alkeon Capital Management, Insight Partners, Silverton Partners, Pacific Western Bank, Pritzker Group Venture Capital, GFR Fund, Colorcon Ventures, and others. The company raised $100M in Series C round on Jan 19, 2022. This brings Apprentice's total funding to $142M to date.